ALPI and colitis: Ramasamy et al. [26] evaluated the potential therapeutic role for orally administered IAP in two independent mouse models of chronic colitis, namely, DSS-induced mouse colitis model in both wild-type mice and IAP-knockout mice, and the irradiation affected mice deficient in Wiskott-Aldrich Syndrome Protein (WASP) colitis.